BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16879578)

  • 1. Longterm visual prognosis in Usher syndrome types 1 and 2.
    Sadeghi AM; Eriksson K; Kimberling WJ; Sjöström A; Möller C
    Acta Ophthalmol Scand; 2006 Aug; 84(4):537-44. PubMed ID: 16879578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual impairment in Finnish Usher syndrome type III.
    Plantinga RF; Pennings RJ; Huygen PL; Sankila EM; Tuppurainen K; Kleemola L; Cremers CW; Deutman AF
    Acta Ophthalmol Scand; 2006 Feb; 84(1):36-41. PubMed ID: 16445437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course of visual field loss in patients with Type 2 Usher syndrome.
    Fishman GA; Bozbeyoglu S; Massof RW; Kimberling W
    Retina; 2007 Jun; 27(5):601-8. PubMed ID: 17558323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene.
    Herrera W; Aleman TS; Cideciyan AV; Roman AJ; Banin E; Ben-Yosef T; Gardner LM; Sumaroka A; Windsor EA; Schwartz SB; Stone EM; Liu XZ; Kimberling WJ; Jacobson SG
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2651-60. PubMed ID: 18281613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a.
    Pennings RJ; Huygen PL; Orten DJ; Wagenaar M; van Aarem A; Kremer H; Kimberling WJ; Cremers CW; Deutman AF
    Acta Ophthalmol Scand; 2004 Apr; 82(2):131-9. PubMed ID: 15043528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal central retinal function and structure preserved in retinitis pigmentosa.
    Jacobson SG; Roman AJ; Aleman TS; Sumaroka A; Herrera W; Windsor EA; Atkinson LA; Schwartz SB; Steinberg JD; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1079-85. PubMed ID: 19797198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older.
    Grover S; Fishman GA; Anderson RJ; Tozatti MS; Heckenlively JR; Weleber RG; Edwards AO; Brown J
    Ophthalmology; 1999 Sep; 106(9):1780-5. PubMed ID: 10485550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of visual field progression in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Brown J
    Ophthalmology; 1998 Jun; 105(6):1069-75. PubMed ID: 9627658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and cochlear implantation in Usher syndrome type I.
    Damen GW; Pennings RJ; Snik AF; Mylanus EA
    Laryngoscope; 2006 May; 116(5):723-8. PubMed ID: 16652078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usher syndrome: an otoneurologic study.
    Möller CG; Kimberling WJ; Davenport SL; Priluck I; White V; Biscone-Halterman K; Odkvist LM; Brookhouser PE; Lund G; Grissom TJ
    Laryngoscope; 1989 Jan; 99(1):73-9. PubMed ID: 2909824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usher's syndrome--case report.
    Kwiecień S; Sulak R; Szaflik J
    Klin Oczna; 2008; 110(10-12):384-6. PubMed ID: 19195172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usher syndrome].
    Preda M; Damian C; Irimia A; Sollosy M; Ciuca CA; Totolin M
    Oftalmologia; 2008; 52(4):40-3. PubMed ID: 19354161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation.
    Lenassi E; Saihan Z; Cipriani V; Le Quesne Stabej P; Moore AT; Luxon LM; Bitner-Glindzicz M; Webster AR
    Ophthalmology; 2014 Feb; 121(2):580-7. PubMed ID: 24199935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual acuity and visual field impairment in Usher syndrome.
    Edwards A; Fishman GA; Anderson RJ; Grover S; Derlacki DJ
    Arch Ophthalmol; 1998 Feb; 116(2):165-8. PubMed ID: 9488267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Usher's syndrome associated with psychotic symptoms: diagnosis and follow-up in a psychiatric unit].
    Viala A; Nicot T; Levy F; Vacheron MN
    Encephale; 2009 Jun; 35(3):286-91. PubMed ID: 19540416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution visual fields in children surgically treated for bilateral congenital cataract.
    Martin L; Magnusson G; Popovic Z; Sjöstrand J
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3730-3. PubMed ID: 18344447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.